Open Access. Powered by Scholars. Published by Universities.®

Science and Technology Studies Commons

Open Access. Powered by Scholars. Published by Universities.®

Stéphanie Corde

Eye

Articles 1 - 2 of 2

Full-Text Articles in Science and Technology Studies

I-125 Ropes Eye Plaque Dosimetry: Validation Of A Commercial 3d Ophthalmic Brachytherapy Treatment Planning System And Independent Dose Calculation Software With Gafchromic Ebt3 Films, Joel Poder, Stephanie Corde Apr 2014

I-125 Ropes Eye Plaque Dosimetry: Validation Of A Commercial 3d Ophthalmic Brachytherapy Treatment Planning System And Independent Dose Calculation Software With Gafchromic Ebt3 Films, Joel Poder, Stephanie Corde

Stéphanie Corde

Purpose: The purpose of this study was to measure the dose distributions for different Radiation Oncology Physics and Engineering Services, Australia (ROPES) type eye plaques loaded with I-125 (model 6711) seeds using GafChromic R EBT3 films, in order to verify the dose distributions in the Plaque SimulatorTM (PS) ophthalmic 3D treatment planning system. The brachytherapy module of RADCALC R was used to independently check the dose distributions calculated by PS. Correction factors were derived from the measured data to be used in PS to account for the effect of the stainless steel ROPES plaque backing on the 3D dose distribution. …


Ropes Eye Plaque Dosimetry: Commissioning And Verification Of An Ophthalmic Brachytherapy Treatment Planning System, J Poder, N Annabell, M Geso, M Alqathami, S Corde Feb 2014

Ropes Eye Plaque Dosimetry: Commissioning And Verification Of An Ophthalmic Brachytherapy Treatment Planning System, J Poder, N Annabell, M Geso, M Alqathami, S Corde

Stéphanie Corde

In this study, the Plaque SimulatorTM eye plaque brachytherapy planning system was commissioned for ROPES eye plaques and Amersham Health model 6711 Iodine 125 seeds, using TG43-UI data. The brachytherapy module of the RADCALC® independent checking program was configured to allow verification of the accuracy of the dose calculated by Plaque SimulatorTM. Central axis depth dose distributions were compared and observed to agree to within 2% for all ROPES plaque models and depths of interest. Experimental measurements were performed with a customized PRESAGEm 3-D type dosimeter to validate the calculated depth dose distributions. Preliminary results have shown the effect of …